Literature DB >> 11571945

Prognostic significance of synchronous and metachronous bilateral breast cancer.

J Kollias1, I O Ellis, C W Elston, R W Blamey.   

Abstract

Women previously treated for primary operable breast cancer are at increased risk of developing cancer in the contralateral breast, but the clinical significance of this development is unclear. The purpose of this study was to assess the impact of synchronous bilateral breast cancer or the development of a metachronous contralateral breast primary on the prognosis. In a series of 3210 women age < or = 70 years treated between 1975 and 1995 for primary operable breast cancer, 106 were identified to have bilateral breast cancer. Of these women, 26 were noted to have synchronous bilateral breast primaries (0.8%), and 80 developed a contralateral breast cancer after treatment for an initial primary breast cancer. Using life-tables analysis, there was a significant difference in survival between women with unilateral breast cancer, those with synchronous bilateral breast cancers, and those with metachronous contralateral breast with survivals at 16 years of 53.8%, 42.4%, and 60.1%, respectively (p < 0.0001), from the date of the diagnosis of the first primary tumor. There was no difference in survival seen between the three groups when survival was calculated from the date of diagnosis of the second primary in cases of metachronous contralateral breast cancer (p = 0.31). When contralateral breast cancer was incorporated as a time-dependent covariate in a Cox multivariate model together with the three factors used to determine the Nottingham Prognostic Index (invasive tumor size, grade, and lymph node stage), contralateral breast cancer continued to be a significant prognostic determinant (p = 0.02). The survival of women with synchronous bilateral breast cancer or metachronous breast cancers diagnosed within 2 years of the original primary was worse than those with unilateral disease. However, the time duration to metachronous contralateral breast cancer did not have prognostic significance in a multivariate model compared with the prognostic features of the original primary.

Entities:  

Mesh:

Year:  2001        PMID: 11571945     DOI: 10.1007/bf03215857

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  30 in total

1.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Clinical and histological predictors of contralateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  Eur J Surg Oncol       Date:  1999-12       Impact factor: 4.424

3.  Bilateral breast carcinomas: Role of mammography.

Authors:  R L Egan
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

4.  Clinical epidemiology of bilateral breast cancer.

Authors:  H Brenner; B Engelsmann; C Stegmaier; H Ziegler
Journal:  Cancer       Date:  1993-12-15       Impact factor: 6.860

5.  Bilateral breast cancer in patients with initial stage I and II disease.

Authors:  S R Schell; E D Montague; W J Spanos; N D Tapley; G H Fletcher; M J Oswald
Journal:  Cancer       Date:  1982-09-15       Impact factor: 6.860

6.  Bilateral primary breast cancer: a prospective study of disease incidence.

Authors:  M A Chaudary; R R Millis; E O Hoskins; M Halder; R D Bulbrook; J Cuzick; J L Hayward
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

7.  Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study.

Authors:  H O Adami; R Bergström; J Hansen
Journal:  Cancer       Date:  1985-02-01       Impact factor: 6.860

8.  Risk of contralateral breast cancer. Associations with histologic, clinical, and therapeutic factors.

Authors:  P L Horn; W D Thompson
Journal:  Cancer       Date:  1988-07-15       Impact factor: 6.860

9.  The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  I Balslev; C K Axelsson; K Zedeler; B B Rasmussen; B Carstensen; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Risk of contralateral breast cancer in Denmark 1943-80.

Authors:  H H Storm; O M Jensen
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

View more
  13 in total

Review 1.  Is symptom-oriented follow-up still up to date?

Authors:  Christoph Mundhenke; Volker Moebus
Journal:  Breast Care (Basel)       Date:  2013-10       Impact factor: 2.860

2.  Pancreatic cancer screening employing noncontrast magnetic resonance imaging combined with ultrasonography.

Authors:  Seiko Kuroki-Suzuki; Yoshifumi Kuroki; Katsuhiro Nasu; Chieko Nagashima; Minoru Machida; Yukio Muramatsu; Noriyuki Moriyama
Journal:  Jpn J Radiol       Date:  2011-05-24       Impact factor: 2.374

3.  Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer.

Authors:  Yan-Xia Shi; Qing Xia; Rou-Jun Peng; Zhong-Yu Yuan; Shu-Sen Wang; Xin An; Ye Cao; Yu-Ting Tan; Ying Jin; Xiu-Yu Cai; Yue-Li Sun; Xiao-Yu Teng; Dong-Geng Liu; Wen-Qi Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

4.  Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.

Authors:  Elżbieta Senkus; Jolanta Szade; Beata Pieczyńska; Anna Zaczek; Joanna Pikiel; Katarzyna Sosińska-Mielcarek; Agnieszka Karpińska; Jacek Jassem
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  Histo-biological comparative analysis of bilateral breast cancer.

Authors:  Bilal Baker; Basem Morcos; Faiez Daoud; Maher Sughayer; Maher Sughayyer; Hisham Shabani; Habeeb Salameh; Mahmoud Almasri
Journal:  Med Oncol       Date:  2013-09-24       Impact factor: 3.064

6.  MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-up.

Authors:  Nanette D Debruhl; Su-Ju Lee; Mary C Mahoney; Lucy Hanna; Catherine Tuite; Constantine A Gatsonis; Constance Lehman
Journal:  J Breast Imaging       Date:  2019-11-08

Review 7.  An overview of prognostic factors for long-term survivors of breast cancer.

Authors:  Isabelle Soerjomataram; Marieke W J Louwman; Jacques G Ribot; Jan A Roukema; Jan Willem W Coebergh
Journal:  Breast Cancer Res Treat       Date:  2007-03-22       Impact factor: 4.872

8.  [Synchronous bilateral breast cancer in Morocco: epidemiological and clinical characteristics].

Authors:  Houssine Boufettal; Naïma Samouh
Journal:  Pan Afr Med J       Date:  2015-02-10

9.  Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women.

Authors:  W-H Kuo; A M-F Yen; P-H Lee; K-M Chen; J Wang; K-J Chang; T H-H Chen; H-S Tsau
Journal:  Br J Cancer       Date:  2009-02-03       Impact factor: 7.640

10.  The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

Authors:  Michael Schaapveld; Otto Visser; W J Louwman; Pax H B Willemse; Elisabeth G E de Vries; Winette T A van der Graaf; Renée Otter; Jan Willem W Coebergh; Flora E van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  2007-08-09       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.